IIL Stock Overview
Intravenous Infusions Plc, a pharmaceutical company, engages in the production and distribution of intravenous infusions and small volume injections for therapeutic purposes in Ghana and the West African sub-region.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Intravenous Infusions Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | GH₵0.05 |
| 52 Week High | GH₵0 |
| 52 Week Low | GH₵0 |
| Beta | 0.42 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 3 Year Change | 0% |
| 5 Year Change | -37.50% |
| Change since IPO | -37.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| IIL | GH Pharmaceuticals | GH Market | |
|---|---|---|---|
| 7D | 0% | 1.1% | 2.0% |
| 1Y | n/a | 15.3% | 35.6% |
Return vs Industry: Insufficient data to determine how IIL performed against the GH Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how IIL performed against the GH Market.
Price Volatility
| IIL volatility | |
|---|---|
| IIL Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 4.3% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in GH Market | 6.0% |
| 10% least volatile stocks in GH Market | 1.0% |
Stable Share Price: IIL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IIL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | n/a | Moukhtar Soalihu | www.iil.com.gh |
Intravenous Infusions Plc, a pharmaceutical company, engages in the production and distribution of intravenous infusions and small volume injections for therapeutic purposes in Ghana and the West African sub-region. The company was incorporated in 1969 and is based in Koforidua, Ghana.
Intravenous Infusions Plc Fundamentals Summary
| IIL fundamental statistics | |
|---|---|
| Market cap | GH₵13.72m |
| Earnings (TTM) | GH₵5.06m |
| Revenue (TTM) | GH₵31.39m |
2.7x
P/E Ratio0.4x
P/S RatioIs IIL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IIL income statement (TTM) | |
|---|---|
| Revenue | GH₵31.39m |
| Cost of Revenue | GH₵13.06m |
| Gross Profit | GH₵18.33m |
| Other Expenses | GH₵13.27m |
| Earnings | GH₵5.06m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.018 |
| Gross Margin | 58.40% |
| Net Profit Margin | 16.12% |
| Debt/Equity Ratio | 64.3% |
How did IIL perform over the long term?
See historical performance and comparison